Global Antiemetics for Cancer Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Report ID: GIR2302010003 | Category: Pharma & Healthcare | Pages: 115 | Format: PDF | Published Date: March 01,2023

Request Sample Enquiry before buying Ask For Discount

Single User-$3480.00 Multi User-$5220.00

Report Description
View Table of Contents

Report Summary

According to our (Global Info Research) latest study, the global Antiemetics for Cancer Treatment market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Emetogenic symptoms are associated with nausea and vomiting associated with cancer treatments such as chemotherapy, radiation therapy, and drug therapy. Nausea and vomiting are major side effects of cancer treatment. It is important that nausea and vomiting are controlled so patients can continue treatment and have a better quality of life. Nausea and vomiting, primarily due to, can also be induced in patients receiving chemotherapy and radiation therapy of the brain, gastrointestinal tract, or liver.
This report is a detailed and comprehensive analysis for global Antiemetics for Cancer Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Antiemetics for Cancer Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Antiemetics for Cancer Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Antiemetics for Cancer Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Antiemetics for Cancer Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antiemetics for Cancer Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antiemetics for Cancer Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Heron Therapeutics, Inc, Sandoz International GmbH, Merck & Co., Inc, Eisai Co., Ltd and Teva Pharmaceutical Industries Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Antiemetics for Cancer Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Serotonin Receptor Antagonists
    Neurokinin-1 Receptor Antagonist
    Corticosteroids
    Olanzapine
    Other
Market segment by Application
    Highly Emetogenic Chemotherapy
    Moderately Emetogenic Chemotherapy
    Low Emetogenic Chemotherapy
Major players covered
    Heron Therapeutics, Inc
    Sandoz International GmbH
    Merck & Co., Inc
    Eisai Co., Ltd
    Teva Pharmaceutical Industries Ltd
    F. Hoffmann-La Roche Ltd
    Mylan N.V
    GSK plc
    Mundipharma International
    Baxter
    Bayer AG
    Cipla Inc
    Sanofi
    Sun Pharmaceutical Industries Ltd
    Qilu Pharmaceutical Co.,Ltd
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antiemetics for Cancer Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antiemetics for Cancer Treatment, with price, sales, revenue and global market share of Antiemetics for Cancer Treatment from 2018 to 2023.
Chapter 3, the Antiemetics for Cancer Treatment competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antiemetics for Cancer Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Antiemetics for Cancer Treatment market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antiemetics for Cancer Treatment.
Chapter 14 and 15, to describe Antiemetics for Cancer Treatment sales channel, distributors, customers, research findings and conclusion.

1 Market Overview
    1.1 Product Overview and Scope of Antiemetics for Cancer Treatment
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Antiemetics for Cancer Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Serotonin Receptor Antagonists
        1.3.3 Neurokinin-1 Receptor Antagonist
        1.3.4 Corticosteroids
        1.3.5 Olanzapine
        1.3.6 Other
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Antiemetics for Cancer Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Highly Emetogenic Chemotherapy
        1.4.3 Moderately Emetogenic Chemotherapy
        1.4.4 Low Emetogenic Chemotherapy
    1.5 Global Antiemetics for Cancer Treatment Market Size & Forecast
        1.5.1 Global Antiemetics for Cancer Treatment Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Antiemetics for Cancer Treatment Sales Quantity (2018-2029)
        1.5.3 Global Antiemetics for Cancer Treatment Average Price (2018-2029) 
2 Manufacturers Profiles
    2.1 Heron Therapeutics, Inc
        2.1.1 Heron Therapeutics, Inc Details
        2.1.2 Heron Therapeutics, Inc Major Business
        2.1.3 Heron Therapeutics, Inc Antiemetics for Cancer Treatment Product and Services
        2.1.4 Heron Therapeutics, Inc Antiemetics for Cancer Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Heron Therapeutics, Inc Recent Developments/Updates
    2.2 Sandoz International GmbH
        2.2.1 Sandoz International GmbH Details
        2.2.2 Sandoz International GmbH Major Business
        2.2.3 Sandoz International GmbH Antiemetics for Cancer Treatment Product and Services
        2.2.4 Sandoz International GmbH Antiemetics for Cancer Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Sandoz International GmbH Recent Developments/Updates
    2.3 Merck & Co., Inc
        2.3.1 Merck & Co., Inc Details
        2.3.2 Merck & Co., Inc Major Business
        2.3.3 Merck & Co., Inc Antiemetics for Cancer Treatment Product and Services
        2.3.4 Merck & Co., Inc Antiemetics for Cancer Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Merck & Co., Inc Recent Developments/Updates
    2.4 Eisai Co., Ltd
        2.4.1 Eisai Co., Ltd Details
        2.4.2 Eisai Co., Ltd Major Business
        2.4.3 Eisai Co., Ltd Antiemetics for Cancer Treatment Product and Services
        2.4.4 Eisai Co., Ltd Antiemetics for Cancer Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Eisai Co., Ltd Recent Developments/Updates
    2.5 Teva Pharmaceutical Industries Ltd
        2.5.1 Teva Pharmaceutical Industries Ltd Details
        2.5.2 Teva Pharmaceutical Industries Ltd Major Business
        2.5.3 Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Product and Services
        2.5.4 Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
    2.6 F. Hoffmann-La Roche Ltd
        2.6.1 F. Hoffmann-La Roche Ltd Details
        2.6.2 F. Hoffmann-La Roche Ltd Major Business
        2.6.3 F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Product and Services
        2.6.4 F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
    2.7 Mylan N.V
        2.7.1 Mylan N.V Details
        2.7.2 Mylan N.V Major Business
        2.7.3 Mylan N.V Antiemetics for Cancer Treatment Product and Services
        2.7.4 Mylan N.V Antiemetics for Cancer Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Mylan N.V Recent Developments/Updates
    2.8 GSK plc
        2.8.1 GSK plc Details
        2.8.2 GSK plc Major Business
        2.8.3 GSK plc Antiemetics for Cancer Treatment Product and Services
        2.8.4 GSK plc Antiemetics for Cancer Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 GSK plc Recent Developments/Updates
    2.9 Mundipharma International
        2.9.1 Mundipharma International Details
        2.9.2 Mundipharma International Major Business
        2.9.3 Mundipharma International Antiemetics for Cancer Treatment Product and Services
        2.9.4 Mundipharma International Antiemetics for Cancer Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Mundipharma International Recent Developments/Updates
    2.10 Baxter
        2.10.1 Baxter Details
        2.10.2 Baxter Major Business
        2.10.3 Baxter Antiemetics for Cancer Treatment Product and Services
        2.10.4 Baxter Antiemetics for Cancer Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Baxter Recent Developments/Updates
    2.11 Bayer AG
        2.11.1 Bayer AG Details
        2.11.2 Bayer AG Major Business
        2.11.3 Bayer AG Antiemetics for Cancer Treatment Product and Services
        2.11.4 Bayer AG Antiemetics for Cancer Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Bayer AG Recent Developments/Updates
    2.12 Cipla Inc
        2.12.1 Cipla Inc Details
        2.12.2 Cipla Inc Major Business
        2.12.3 Cipla Inc Antiemetics for Cancer Treatment Product and Services
        2.12.4 Cipla Inc Antiemetics for Cancer Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Cipla Inc Recent Developments/Updates
    2.13 Sanofi
        2.13.1 Sanofi Details
        2.13.2 Sanofi Major Business
        2.13.3 Sanofi Antiemetics for Cancer Treatment Product and Services
        2.13.4 Sanofi Antiemetics for Cancer Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 Sanofi Recent Developments/Updates
    2.14 Sun Pharmaceutical Industries Ltd
        2.14.1 Sun Pharmaceutical Industries Ltd Details
        2.14.2 Sun Pharmaceutical Industries Ltd Major Business
        2.14.3 Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Product and Services
        2.14.4 Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
    2.15 Qilu Pharmaceutical Co.,Ltd
        2.15.1 Qilu Pharmaceutical Co.,Ltd Details
        2.15.2 Qilu Pharmaceutical Co.,Ltd Major Business
        2.15.3 Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Product and Services
        2.15.4 Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Qilu Pharmaceutical Co.,Ltd Recent Developments/Updates
3 Competitive Environment: Antiemetics for Cancer Treatment by Manufacturer
    3.1 Global Antiemetics for Cancer Treatment Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Antiemetics for Cancer Treatment Revenue by Manufacturer (2018-2023)
    3.3 Global Antiemetics for Cancer Treatment Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Antiemetics for Cancer Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Antiemetics for Cancer Treatment Manufacturer Market Share in 2022
        3.4.2 Top 6 Antiemetics for Cancer Treatment Manufacturer Market Share in 2022
    3.5 Antiemetics for Cancer Treatment Market: Overall Company Footprint Analysis
        3.5.1 Antiemetics for Cancer Treatment Market: Region Footprint
        3.5.2 Antiemetics for Cancer Treatment Market: Company Product Type Footprint
        3.5.3 Antiemetics for Cancer Treatment Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
    4.1 Global Antiemetics for Cancer Treatment Market Size by Region
        4.1.1 Global Antiemetics for Cancer Treatment Sales Quantity by Region (2018-2029)
        4.1.2 Global Antiemetics for Cancer Treatment Consumption Value by Region (2018-2029)
        4.1.3 Global Antiemetics for Cancer Treatment Average Price by Region (2018-2029)
    4.2 North America Antiemetics for Cancer Treatment Consumption Value (2018-2029)
    4.3 Europe Antiemetics for Cancer Treatment Consumption Value (2018-2029)
    4.4 Asia-Pacific Antiemetics for Cancer Treatment Consumption Value (2018-2029)
    4.5 South America Antiemetics for Cancer Treatment Consumption Value (2018-2029)
    4.6 Middle East and Africa Antiemetics for Cancer Treatment Consumption Value (2018-2029)
5 Market Segment by Type
    5.1 Global Antiemetics for Cancer Treatment Sales Quantity by Type (2018-2029)
    5.2 Global Antiemetics for Cancer Treatment Consumption Value by Type (2018-2029)
    5.3 Global Antiemetics for Cancer Treatment Average Price by Type (2018-2029)
6 Market Segment by Application
    6.1 Global Antiemetics for Cancer Treatment Sales Quantity by Application (2018-2029)
    6.2 Global Antiemetics for Cancer Treatment Consumption Value by Application (2018-2029)
    6.3 Global Antiemetics for Cancer Treatment Average Price by Application (2018-2029)
7 North America
    7.1 North America Antiemetics for Cancer Treatment Sales Quantity by Type (2018-2029)
    7.2 North America Antiemetics for Cancer Treatment Sales Quantity by Application (2018-2029)
    7.3 North America Antiemetics for Cancer Treatment Market Size by Country
        7.3.1 North America Antiemetics for Cancer Treatment Sales Quantity by Country (2018-2029)
        7.3.2 North America Antiemetics for Cancer Treatment Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
    8.1 Europe Antiemetics for Cancer Treatment Sales Quantity by Type (2018-2029)
    8.2 Europe Antiemetics for Cancer Treatment Sales Quantity by Application (2018-2029)
    8.3 Europe Antiemetics for Cancer Treatment Market Size by Country
        8.3.1 Europe Antiemetics for Cancer Treatment Sales Quantity by Country (2018-2029)
        8.3.2 Europe Antiemetics for Cancer Treatment Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
    9.1 Asia-Pacific Antiemetics for Cancer Treatment Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Antiemetics for Cancer Treatment Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Antiemetics for Cancer Treatment Market Size by Region
        9.3.1 Asia-Pacific Antiemetics for Cancer Treatment Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Antiemetics for Cancer Treatment Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
    10.1 South America Antiemetics for Cancer Treatment Sales Quantity by Type (2018-2029)
    10.2 South America Antiemetics for Cancer Treatment Sales Quantity by Application (2018-2029)
    10.3 South America Antiemetics for Cancer Treatment Market Size by Country
        10.3.1 South America Antiemetics for Cancer Treatment Sales Quantity by Country (2018-2029)
        10.3.2 South America Antiemetics for Cancer Treatment Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
    11.1 Middle East & Africa Antiemetics for Cancer Treatment Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Antiemetics for Cancer Treatment Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Antiemetics for Cancer Treatment Market Size by Country
        11.3.1 Middle East & Africa Antiemetics for Cancer Treatment Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Antiemetics for Cancer Treatment Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
    12.1 Antiemetics for Cancer Treatment Market Drivers
    12.2 Antiemetics for Cancer Treatment Market Restraints
    12.3 Antiemetics for Cancer Treatment Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
    13.1 Raw Material of Antiemetics for Cancer Treatment and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Antiemetics for Cancer Treatment
    13.3 Antiemetics for Cancer Treatment Production Process
    13.4 Antiemetics for Cancer Treatment Industrial Chain
14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Antiemetics for Cancer Treatment Typical Distributors
    14.3 Antiemetics for Cancer Treatment Typical Customers
15 Research Findings and Conclusion
16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

FAQ's

What does the report cover (Scope)?

It contains all the geographic trends, and market analysis for global market

ENTER REPORT NAME TO SEARCH

Global Antiemetics for Cancer Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Report Summary

Table of Contents

FAQ's

What does the report cover (Scope)?